Burnout Rates High Among Physicians Treating Sickle Cell Disease

Physicians specializing in sickle cell disease (SCD) report significantly higher rates of burnout compared to their hematology-oncology colleagues who do not treat this condition, according to a recent study published in Blood Advances, the journal of the American Society of Hematology (ASH). The findings highlight the unique challenges faced by clinicians caring for individuals with SCD and underscore the require for institutional support to address these disparities.

Study Details and Findings

The cross-sectional, nationwide survey assessed burnout among 159 hematology-oncology physicians. Of those, 55 focused on treating sickle cell disease. Researchers found that 60% of physicians treating SCD experienced burnout, compared to 43% of those who did not. This difference persisted even when accounting for grit and resilience levels, suggesting factors beyond individual coping mechanisms contribute to burnout in this specialty.

Several factors were identified as potentially contributing to the higher burnout rates:

• Income Disparity: 40% of SCD physicians reported annual incomes under $350,000, compared to 64% of their colleagues.
• Job Pride and Recreation Time: Lower job pride and less time for recreation were directly associated with increased burnout.

The survey also revealed demographic differences: 71% of respondents identified as female, and 59% as white. Though, physicians treating SCD were more likely to identify as Black (24%) compared to those who did not (4%). The median age of respondents was 43.

The Complexities of Sickle Cell Disease Care

Sickle cell disease is a chronic inherited blood disorder affecting approximately 100,000 individuals in the United States, with one in every 365 Black births impacted. The disorder is characterized by abnormally shaped red blood cells that can block blood flow, leading to organ damage, infection, and severe pain episodes. Caring for these patients requires physicians to manage ongoing demands in both inpatient and outpatient settings, navigate limited treatment options, and address persistent gaps in education that contribute to disparities in care.

Study Limitations and Future Research

The researchers acknowledge limitations of the study, including self-selection bias and a prioritization of brevity over detailed data collection. The use of a single-item burnout questionnaire and the inability to calculate a response rate due to the survey distribution method also represent limitations.

This initial survey is part of a larger effort to understand burnout in SCD providers. A follow-up survey is currently underway, assessing programmatic factors that may influence burnout among clinicians.

ASH Guidelines and Support

The American Society of Hematology (ASH) has been actively developing clinical practice guidelines for sickle cell disease since 2016. These guidelines, regularly reviewed and updated, aim to provide the most current evidence-based treatment recommendations. ASH also offers resources such as the ASH Clinical Practice Guidelines App and teaching slides to support clinicians in diagnosing, managing, and treating SCD.

“Identifying the underlying reasons for these trends can give us a tangible plan to mitigate the frequency of burnout in sickle cell providers and reduce the associated risks posed to patients,” said Valentina Restrepo-Espinosa, MD, a postdoctoral associate at Yale School of Medicine.